Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms
about
Aspirin with or without an antiemetic for acute migraine headaches in adultsAspirin with or without an antiemetic for acute migraine headaches in adultsEvidence-Based Treatments for Adults with MigraineOptimal management of severe nausea and vomiting in migraine: improving patient outcomesMigraine pathogenesis and state of pharmacological treatment optionsMigraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women's Health Study.Evaluation of onset of pain relief from micronized aspirin in a dental pain modelA review of current European treatment guidelines for migraineSurvey of migraine sufferers with dogs to evaluate for canine migraine-alerting behaviors.Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment.Are the current IHS guidelines for migraine drug trials being followed?Headache: insight, understanding, treatment and patient management.Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs.COX inhibitors for the treatment of migraine.Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches.Drug safety in acute migraine treatment.Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists.Delayed absorption of many (paracetamol, aspirin, other NSAIDs and zolmitriptan) but not all (sumatriptan, rizatriptan) drugs during migraine attacks and most likely normal gastric emptying outside attacks. A review.Aspirin is first-line treatment for migraine and episodic tension-type headache regardless of headache intensity.Suggested randomised, controlled trial with frovatriptan.Nitroglycerin provocation in normal subjects is not a useful human migraine model?Suggested randomized, controlled trial for frovatriptan: a reply.Migraine: possible role of shear-induced platelet aggregation with serotonin release.The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine.Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.
P2860
Q24197721-A9578545-42E6-4A31-96BB-823AF3136BF3Q24235987-926E96AD-30BA-45DE-80DE-C2548509E28BQ26769968-CE365128-5C87-4574-B383-DFE93C65D1DEQ26830422-C226549F-6BE1-46A5-BC43-62AF96100D3BQ30886663-B1C0E18B-4017-4D4C-AE09-C7D042BF87F5Q35127126-EAD16243-8301-4C95-9D68-4414F6BF1FBCQ36098978-ECE2E96C-01F1-4963-A9A2-D3DC1F46D2BAQ36260873-363FBA11-004B-4A4D-ACCA-0D8EDEA01C0AQ36905219-3E0343F5-D857-424E-ACAD-1FF1A869C866Q37123478-9A61E1A7-CC46-4B0C-8B82-1D1D97862C22Q37798757-5DA4E6CF-C8E9-4799-A03E-D6CACEFB87BAQ38060827-1D5B77A5-E2F6-462F-89A9-DE3556524F80Q38066258-498E34A0-9820-4AB6-A8B8-B9A3E8F2479CQ38167355-98E88405-31D1-4804-BB42-BE95C01B7E54Q38227997-A02BB41C-E59C-4888-A85F-038B25470AAEQ38248973-B9586620-F808-4636-A33F-6FC0A381CC29Q38378898-FB7055E3-00B8-48E2-86C6-ADFABF91C6BFQ38533414-6689379F-9E9A-4B33-AFB8-BE769A916250Q38872695-F309C3D6-EDC0-40DA-BDD5-FBAE16FF306AQ39260096-12FDF912-CB8D-4C9F-A833-BAFC5140978BQ42957882-030656F6-7F2F-4C85-800E-B78EC7E93658Q43279154-A9A9A115-8759-4C37-8A6A-C4440D792BC8Q45814885-305AE939-6AFE-4236-B924-821A26637BFCQ47793574-36DF20A0-6984-4384-9CBF-DAB1FD093E7DQ48021540-F441F517-EB7D-4762-9096-0A025A2043FCQ49873285-216C1C97-EA32-4AF3-9C21-6C9AA3DFC75C
P2860
Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@ast
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@en
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@nl
type
label
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@ast
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@en
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@nl
prefLabel
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@ast
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@en
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@nl
P2860
P921
P1433
P1476
Efficacy and safety of 1,000 m ...... migraine accompanying symptoms
@en
P2093
Christian Lampl
P2860
P2888
P304
P356
10.1007/S00415-007-0547-2
P407
P577
2007-06-01T00:00:00Z
P5875
P6179
1041989649